BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12835692)

  • 1. Dengue immune response: low affinity, high febrility.
    Welsh RM; Rothman AL
    Nat Med; 2003 Jul; 9(7):820-2. PubMed ID: 12835692
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
    Yeh WT; Chen RF; Wang L; Liu JW; Shaio MF; Yang KD
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):84-90. PubMed ID: 16965355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.
    Mongkolsapaya J; Dejnirattisai W; Xu XN; Vasanawathana S; Tangthawornchaikul N; Chairunsri A; Sawasdivorn S; Duangchinda T; Dong T; Rowland-Jones S; Yenchitsomanus PT; McMichael A; Malasit P; Screaton G
    Nat Med; 2003 Jul; 9(7):921-7. PubMed ID: 12808447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
    Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS
    J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
    Green S; Rothman A
    Curr Opin Infect Dis; 2006 Oct; 19(5):429-36. PubMed ID: 16940865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia.
    Appanna R; Huat TL; See LL; Tan PL; Vadivelu J; Devi S
    Clin Vaccine Immunol; 2007 Aug; 14(8):969-77. PubMed ID: 17567768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte responses to heterologous secondary dengue virus infections.
    Rothman AL
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E36-41. PubMed ID: 19751400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
    Kurane I
    Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):329-40. PubMed ID: 17645944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
    Fink J; Gu F; Vasudevan SG
    Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of Dengue hemorrhagic fever.
    Rothman AL; Ennis FA
    Virology; 1999 Apr; 257(1):1-6. PubMed ID: 10208914
    [No Abstract]   [Full Text] [Related]  

  • 11. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever.
    Wang WK; Chen HL; Yang CF; Hsieh SC; Juan CC; Chang SM; Yu CC; Lin LH; Huang JH; King CC
    Clin Infect Dis; 2006 Oct; 43(8):1023-30. PubMed ID: 16983615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue and yellow fever--challenges for the development and use of vaccines.
    Monath TP
    N Engl J Med; 2007 Nov; 357(22):2222-5. PubMed ID: 18046026
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathogenesis of dengue virus diseases: missing pieces in the jigsaw.
    Bielefeldt-Ohmann H
    Trends Microbiol; 1997 Oct; 5(10):409-13. PubMed ID: 9351178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding dengue pathogenesis: implications for vaccine design.
    Stephenson JR
    Bull World Health Organ; 2005 Apr; 83(4):308-14. PubMed ID: 15868023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of cellular immune responses in the acute phase of dengue virus infection.
    Yoshida T; Omatsu T; Saito A; Katakai Y; Iwasaki Y; Kurosawa T; Hamano M; Higashino A; Nakamura S; Takasaki T; Yasutomi Y; Kurane I; Akari H
    Arch Virol; 2013 Jun; 158(6):1209-20. PubMed ID: 23381396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever.
    Chen RF; Liu JW; Yeh WT; Wang L; Chang JC; Yu HR; Cheng JT; Yang KD
    FEMS Immunol Med Microbiol; 2005 Apr; 44(1):43-50. PubMed ID: 15780577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient CD4/CD8 ratio inversion and aberrant immune activation during dengue virus infection.
    Liu CC; Huang KJ; Lin YS; Yeh TM; Liu HS; Lei HY
    J Med Virol; 2002 Oct; 68(2):241-52. PubMed ID: 12210415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue.
    Adams B; Boots M
    J Theor Biol; 2006 Sep; 242(2):337-46. PubMed ID: 16631802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner.
    Beaumier CM; Mathew A; Bashyam HS; Rothman AL
    J Infect Dis; 2008 Feb; 197(4):608-17. PubMed ID: 18275279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global voices of science. Deciphering dengue: the Cuban experience.
    Guzmán MG
    Science; 2005 Sep; 309(5740):1495-7. PubMed ID: 16141052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.